​

Natera (NTRA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NTRA Stock Forecast

Natera (NTRA) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $154.80, with a high of $182.00 and a low of $132.00. This represents a -7.98% decline from the last price of $168.22.

$50 $80 $110 $140 $170 $200 High: $182 Avg: $154.8 Low: $132 Last Closed Price: $168.22

NTRA Stock Rating

Natera stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 1 Strong Buy (9.09%), 10 Buy (90.91%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 10 1 Strong Sell Sell Hold Buy Strong Buy

NTRA Forecast vs Benchmarks

TypeNameUpside
StockNatera-7.98%
SectorHealthcare Stocks 25.20%
IndustryDiagnostics & Research Stocks16.01%

Price Target Trends

1M3M12M
# Anlaysts-213
Avg Price Target-$171.00$138.31
Last Closing Price$168.22$168.22$168.22
Upside/Downside-1.65%-17.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25612--119
Dec, 24512--118
Nov, 24612--119
Oct, 24812-1122
Sep, 24812-1122
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 13, 2024Tycho PetersonJefferies$182.00$114.5758.85%8.19%
Nov 13, 2024Catherine Ramsey SchulteRobert W. Baird$160.00$114.5739.65%-4.89%
Oct 29, 2024Kyle MiksonCanaccord Genuity$150.00$120.7124.26%-10.83%
Sep 13, 2024Dave WestenbergPiper Sandler$150.00$125.1219.88%-10.83%
Aug 27, 2024Kyle MiksonCanaccord Genuity$145.00$118.1122.77%-13.80%
Aug 13, 2024Tejas SavantMorgan Stanley$132.00$115.2514.53%-21.53%
Aug 09, 2024Catherine Ramsey SchulteRobert W. Baird$120.00$107.7011.42%-28.66%
Jun 25, 2024Doug SchenkelWolfe Research$135.00$107.4125.69%-19.75%
Jun 03, 2024Tycho PetersonJefferies$142.00$106.5333.30%-15.59%
May 14, 2024David WestenbergPiper Sandler$120.00$103.3316.13%-28.66%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jan 10, 2025BernsteinOutperformOutperformhold
Nov 13, 2024Cowen & Co.BuyBuyhold
Nov 13, 2024JefferiesBuyBuyhold
Oct 29, 2024Canaccord GenuityBuyBuyhold
Oct 16, 2024UBSBuyBuyhold
Sep 16, 2024BTIGBuyBuyhold
Sep 13, 2024UBSBuyBuyhold
Sep 13, 2024Piper SandlerOverweightOverweighthold
Sep 10, 2024Cowen & Co.BuyBuyhold
Aug 27, 2024Canaccord GenuityBuyBuyhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.84$-5.21$-5.57$-3.78-----
Avg Forecast$-2.54$-5.02$-5.60$-3.96$-1.50$-1.20$0.02$0.98$1.46
High Forecast$-2.69$-5.32$-5.85$-4.05$-1.61$-1.51$-0.15$0.18$1.33
Low Forecast$-2.48$-4.90$-5.26$-3.87$-1.22$-0.79$0.37$2.21$1.53
Surprise %11.81%3.78%-0.54%-4.55%-----

Revenue Forecast

$0 $600M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$391.00M$625.49M$820.22M$1.08B-----
Avg Forecast$385.24M$621.43M$819.43M$1.07B$1.65B$1.82B$2.14B$2.46B$2.68B
High Forecast$378.23M$610.12M$780.38M$1.06B$1.64B$1.78B$2.14B$2.45B$2.50B
Low Forecast$403.22M$650.44M$846.85M$1.09B$1.66B$1.88B$2.15B$2.46B$2.79B
Surprise %1.50%0.65%0.10%1.17%-----

Net Income Forecast

$-600M $-420M $-240M $-60M $120M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-229.74M$-471.72M$-547.80M$-434.80M-----
Avg Forecast$-182.75M$-398.29M$-395.34M$-499.34M$-162.83M$-145.21M$33.61M$168.67M$167.89M
High Forecast$-219.30M$-477.94M$-474.40M$-599.21M$-185.46M$-173.31M$-17.72M$20.83M$152.77M
Low Forecast$-146.20M$-318.63M$-316.27M$-399.47M$-140.20M$-90.38M$42.22M$253.93M$176.39M
Surprise %25.71%18.44%38.57%-12.93%-----

NTRA Forecast FAQ

Is Natera stock a buy?

Natera stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 10 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Natera is a favorable investment for most analysts.

What is Natera's price target?

Natera's price target, set by 11 Wall Street analysts, averages $154.8 over the next 12 months. The price target range spans from $132 at the low end to $182 at the high end, suggesting a potential -7.98% change from the previous close price of $168.22.

How does Natera stock forecast compare to the average forecast of its sector, industry, and investment themes?

Natera stock forecast shows a -7.98% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the diagnostics & research stocks industry (16.01%).

What is the breakdown of analyst ratings for Natera over the past three months?

  • January 2025: 31.58% Strong Buy, 63.16% Buy, 0% Hold, 0% Sell, 5.26% Strong Sell.
  • December 2024: 27.78% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 5.56% Strong Sell.
  • November 2024: 31.58% Strong Buy, 63.16% Buy, 0% Hold, 0% Sell, 5.26% Strong Sell.

What is Natera’s EPS forecast?

Natera's average annual EPS forecast for its fiscal year ending in December is -1.5 for 2024, a -60.32% decrease from the reported $-3.78 in 2023. The prediction for 2025 is $-1.2, $0.02 for 2026, $0.98 for 2027, and $1.46 for 2028.

What is Natera’s revenue forecast?

Natera's average annual revenue forecast for its fiscal year ending in December is $1.65B for 2024, a 52.60% increase from the reported $1.08B in 2023. The forecast for 2025 is $1.82B, $2.14B for 2026, $2.46B for 2027, and $2.68B for 2028.

What is Natera’s net income forecast?

For its fiscal year ending in December, Natera's average annual net income forecast is $-163M for 2024, reflecting a -62.55% decrease from the reported $-435M in 2023. The projection for 2025 is $-145M, $33.61M for 2026, $168.67M for 2027, and $167.89M for 2028.